Sedation of Morbidly Obese for Balloon Insertion

Not Applicable

• Conditions: Morbid Obesity
• Interventions: Drug: Fentanyl; Drug: Ketamine

• Registration Number: NCT03747094
• Lead Sponsor: Mansoura University

Brief Summary

This prospective study will assess the value of different supplements to orpofol bases anesthesia in morbidly obes e patients scheduled for balloon insertion. Two common drugs will be added to propofol bases anesthesia;Ketamine or fentanyl. Effect on prpofol consumption, post-procedure recovery profile, and patient satisfaction will be the study objectives.

Detailed Description

Not available

Study Timeline

• Status Verified: 2018-11
• Study First Submitted: 2018-11-13
• Study First Submitted QC: 2018-11-17
• Last Update Submitted: 2018-11-17
• Study First Posted: 2018-11-20
• Last Update Posted: 2018-11-20
• Study Start: 2018-12-01
• Primary Completion: 2019-03-20
• Study Completion: 2019-04-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• morbid obese indicated for gastric balloon insertion

Exclusion Criteria

• Refusal Hypersensitivity to any of the study drugs

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Fentanyl group	Fentanyl	-
Ketamine group	Ketamine	-

Primary Outcome Measures

Name	Time	Method
Propofol consumption (milligrams)	24 hours after the endoscopy	Dose of prpofol (mg/kg) required for sedation during gastric balloon insertion

Trial Locations

Locations (1)

Mansoura university; 🇪🇬 Al Manşūrah, Dkahleya, Egypt